Pdl Biopharma, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/20 FY 2020

ended 09/30/20 Q3

Late quarterly filing notification for Q3 2020

ended 06/30/20 Q2

ended 03/31/20 Q1

Prospectuses and Registrations Filter

Issuer tender offer – amended

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Ownership Filter

Dimensional Fund Advisors LP

Dimensional Fund Advisors LP

Dimensional Fund Advisors LP

Dimensional Fund Advisors LP

Brandes Investment Partners, LP

News Filter

Enters Into $51.4 Million Capital Provision Agreement With Epps Investments LLC Regarding PDL’s Previously Announced Settlement Agreement With Wellstat

Announces Timeline for Voluntarily Delisting From Nasdaq

Reports 2020 Third Quarter Financial Results and Sets Date to File a Certificate of Dissolution

Unaudited Pro Forma Condensed Consolidated Financial Information

Completes Spin-Off of LENSAR

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary revised proxy

Preliminary revised proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness